Find the right fit for you - faster
Get tailored insights about working at Acadia Pharmaceuticals in one quick step.
Acadia Pharmaceuticals Snapshot
At Acadia Pharmaceuticals, our mission is simple but powerful: Turn scientific potential into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world.
At Acadia, we’re here to make a real difference for patients who are often overlooked. Our commercial portfolio includes FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome, addressing critical unmet needs.
Building on this foundation of excellence, we are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs.
If you’re inspired by purpose, patients, and meaningful impact, you’ll feel right at home here!
Building on this foundation of excellence, we are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs.
If you’re inspired by purpose, patients, and meaningful impact, you’ll feel right at home here!
